Skip to main content

SARS (Severe Acute Respiratory Syndrome) clinical trials at UC Health

1 research study open to eligible people

Showing trials for
  • Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

    open to eligible people ages 18-80

    This is a clinical study for the prevention of SARS-CoV-2 infection in adults exposed to the virus. This study will enroll up to 2000 asymptomatic men and women 18 to 80 years of age (inclusive) who are close contacts of persons with laboratory confirmed SARS-CoV-2 or clinically suspected COVID-19. Eligible participants will be enrolled and randomized to receive the intervention or placebo at the level of the household (all eligible participants in one household will receive the same intervention).

    at UCLA

Last updated: